ampakine
Biovail acquires Ampakine compounds from Cortex Pharma for respiratory depression treatment (PharmaBiz)
March 29th, 2010
Biovail Corporation announced that its subsidiary, Biovail Laboratories International SRL (BLS), has acquired certain Ampakine compounds, including associated intellectual property, from Cortex Pharmaceuticals, Inc. (Cortex) for use in the field of respiratory depression, a brain-mediated breathing disorder…….click here to continue reading